Clinical Trials Directory

Trials / Completed

CompletedNCT00927628

Macular Hole Reopening

Incidence and Factors Related to Macular Hole Reopening

Status
Completed
Phase
Study type
Observational
Enrollment
831 (actual)
Sponsor
Shinjo Ophthalmologic Institute · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers

Summary

The purpose of this investigation was to determine the incidence and the factors that cause a reopening of a macular hole (MH) after a surgical closure.

Detailed description

A reopening of a macular hole (MH) is a well-known complication of successfully closed MHs. Recently, internal limiting membrane (ILM) peeling has become widely used as an adjunctive procedure during MH surgery. The incidence of a reopening of a MH is 0 to 8.6% in eyes in which the ILM was peeled off, and 2 to 16% in which the ILM was not peeled off. Part of the variation in the percentages of reopening was the length of the follow-up period; eyes with longer follow-up periods have higher incidences of reopening.

Conditions

Interventions

TypeNameDescription
PROCEDUREVitrectomyPatients underwent vitrectomy with or without internal limiting membrane (ILM) peeling for an idiopathic full-thickness macular holes. Simultaneous phacoemulsification with intraocular lens implantation was performed on all phakic patients who were \>40-years-of-age.

Timeline

Start date
1990-10-01
Primary completion
2008-12-01
Completion
2008-12-01
First posted
2009-06-25
Last updated
2009-06-25

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00927628. Inclusion in this directory is not an endorsement.